Dosimetry estimation and preliminary clinical application of [ 99m Tc]Tc-HYNIC-PSMA-XL-2 in prostate cancer.
Hongxing YangZhiqi GaoXiaoping XuChang LiuSilong HuJianping ZhangShaoli SongPublished in: Annals of nuclear medicine (2022)
Tc]Tc-HYNIC-PSMA-XL-2 is a safe SPECT/CT tracer, which can detect prostate malignant lesions without interference from the bladder. In addition, the malignant lesions of the lymph node and bone of PCa patients also can be detected efficiently.
Keyphrases
- prostate cancer
- pet ct
- lymph node
- pet imaging
- end stage renal disease
- ejection fraction
- radical prostatectomy
- newly diagnosed
- chronic kidney disease
- positron emission tomography
- spinal cord injury
- bone mineral density
- peritoneal dialysis
- radiation therapy
- neoadjuvant chemotherapy
- benign prostatic hyperplasia
- early stage
- dual energy
- bone regeneration
- locally advanced